0001415889-24-002393.txt : 20240202 0001415889-24-002393.hdr.sgml : 20240202 20240202183006 ACCESSION NUMBER: 0001415889-24-002393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alrutz Michael Albert CENTRAL INDEX KEY: 0001422345 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 24593308 MAIL ADDRESS: STREET 1: 2530 MERIDIAN PARKWAY STREET 2: 2ND FLOOR CITY: DURHAM STATE: NC ZIP: 27713 FORMER NAME: FORMER CONFORMED NAME: Alrutz Michael A DATE OF NAME CHANGE: 20080102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 form4-02022024_110241.xml X0508 4 2024-02-01 0001117480 CHIMERIX INC CMRX 0001422345 Alrutz Michael Albert C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 false true false false SVP AND GENERAL COUNSEL 0 Common Stock 2024-02-01 4 A 0 21875 0 A 168098 D Stock Option (Right to Buy) .93 2024-02-01 4 A 0 131250 0 A 2034-01-31 Common Stock 131250 131250 D The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 5,468 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 5,471 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant. Includes 1,809 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2023 and 2,399 shares acquired under the ESPP on September 8, 2023. 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant. /s/ Michael Alrutz, Attorney-in-Fact 2024-02-02